Translational applications of flow cytometry in clinical practice

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4715-4719

  Jaye, David L ^a,b   Bray, Robert A ^a   Gebel, Howard M ^a   Harris, Wayne A C ^a,b   Waller, Edmund K ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN DETECTION; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOINFORMATICS; CANCER CLASSIFICATION; CELL POPULATION; CELL THERAPY; CELL TRANSPLANTATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DNA CONTENT; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOLOGIC MALIGNANCY; HLA TYPING; HODGKIN DISEASE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; COMPUTATIONAL BIOLOGY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; PATHOLOGY, CLINICAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84861127516     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1290017     Document Type: Review

References (32)

1. Van Dilla, M. A., T. T. Trujillo, P. F. Mullaney, and J. R. Coulter. 1969. Cell microfluorometry: a method for rapid fluorescence measurement. Science 163: 1213-1214.
2. Hulett, H. R., W. A. Bonner, J. Barrett, and L. A. Herzenberg. 1969. Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence. Science 166: 747-749.
3. Köhler, G., and C. Milstein. 1976. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur. J. Immunol. 6: 511-519.
4. Herzenberg, L. A., D. Parks, B. Sahaf, O. Perez, M. Roederer, and L. A. Herzenberg. 2002. The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin. Chem. 48: 1819-1827.
5. Wood, B. L., M. Arroz, D. Barnett, J. DiGiuseppe, B. Greig, S. J. Kussick, T. Oldaker, M. Shenkin, E. Stone, and P. Wallace. 2007. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin. Cytom. 72(Suppl. 1): S14-22. (Pubitemid 350194344)
6. Paiva, B., M. B. Vidriales, J. Cervero, G. Mateo, J. J. Perez, M. A. Montalban, A. Sureda, L. Montejano, N. C. Gutierrez, A. G. de Coca, et al. 2008. GEM/PETHEMA Cooperative Study Groups. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood 112: 4017-4023.
7. Swerdlow, S. H., E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, and J. Vardiman. 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Press, Geneva, Switzerland.
8. Jaye, D. L., C. M. Geigerman, M. Herling, K. Eastburn, E. K. Waller, and D. Jones. 2006. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+CD56+hematodermic neoplasms. Mod. Pathol. 19: 1555-1562. (Pubitemid 44789923)
9. Kraus, T. S., C. N. Sillings, D. F. Saxe, S. Y. Li, and D. L. Jaye. 2010. The role of CD11c expression in the diagnosis of mantle cell lymphoma. Am. J. Clin. Pathol. 134: 271-277.
10. Moreton, P., B. Kennedy, G. Lucas, M. Leach, S. M. Rassam, A. Haynes, J. Tighe, D. Oscier, C. Fegan, A. Rawstron, and P. Hillmen. 2005. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. J. Clin. Oncol. 23: 2971-2979. (Pubitemid 46224116)
11. Barnett, D., B. Walker, A. Landay, and T. N. Denny. 2008. CD4 immunophenotyping in HIV infection. Nat. Rev. Microbiol. 6(Suppl. 11): S7-S15.
12. Oliveira, J. B., L. D. Notarangelo, and T. A. Fleisher. 2008. Applications of flow cytometry for the study of primary immune deficiencies. Curr. Opin. Allergy Clin. Immunol. 8: 499-509.
13. Waller, E. K., H. Rosenthal, T. W. Jones, J. Peel, S. Lonial, A. Langston, I. Redei, I. Jurickova, and M. W. Boyer. 2001. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 97: 2948-2956.
14. Reddy, V., A. G. Winer, E. Eksioglu, H. U. Meier-Kriesche, J. D. Schold, and J. R. Wingard. 2005. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 11: 1014-1021. (Pubitemid 41754720)
15. Subramaniyam, V., E. K. Waller, J. R. Murrow, A. Manatunga, S. Lonial, K. Kasirajan, D. Sutcliffe, W. Harris, W. R. Taylor, R. W. Alexander, and A. A. Quyyumi. 2009. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. Am. Heart J. 158: 53-60.
16. Quyyumi, A. A., E. K. Waller, J. Murrow, F. Esteves, J. Galt, J. Oshinski, S. Lerakis, S. Sher, D. Vaughan, E. Perin, et al. 2011. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am. Heart J. 161: 98-105.
17. Civin, C. I., L. C. Strauss, C. Brovall, M. J. Fackler, J. F. Schwartz, and J. H. Shaper. 1984. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 133: 157-165. (Pubitemid 14076703)
18. Bomberger, C., M. Singh-Jairam, G. Rodey, A. Guerriero, A. M. Yeager, W. H. Fleming, H. K. Holland, and E. K. Waller. 1998. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood 91: 2588-2600. (Pubitemid 28155536)
19. Tricot, G., Y. Gazitt, T. Leemhuis, S. Jagannath, K. R. Desikan, D. Siegel, A. Fassas, S. Tindle, J. Nelson, C. Juttner, et al. 1998. Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma. Blood 91: 4489-4495. (Pubitemid 28270295)
20. Müller, A. M., H. E. Kohrt, S. Cha, G. Laport, J. Klein, A. E. Guardino, L. J. Johnston, K. E. Stockerl-Goldstein, E. Hanania, C. Juttner, et al. 2012. Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells. Biol. Blood Marrow Transplant. 18: 125-133.
21. Michallet, M., T. Philip, I. Philip, H. Godinot, C. Sebban, G. Salles, A. Thiebaut, P. Biron, F. Lopez, P. Mazars, et al. 2000. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp. Hematol. 28: 858-870. (Pubitemid 30411992)
22. Vose, J. M., P. J. Bierman, J. C. Lynch, K. Atkinson, C. Juttner, C. E. Hanania, G. Bociek, and J. O. Armitage. 2001. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol. Blood Marrow Transplant. 7: 680-687. (Pubitemid 34055821)
23. Roncador, G., P. J. Brown, L. Maestre, S. Hue, J. L. Martinez- Torrecuadrada, K. L. Ling, S. Pratap, C. Toms, B. C. Fox, V. Cerundolo, et al. 2005. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35: 1681-1691. (Pubitemid 40862316)
24. Garovoy, M. R., M. A. Rheinschmidt, M. Bigos, H. Perkins, B. Colombe, N. Feduska, and O. Salvatierra. 1983. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation. Transplant. Proc. 15: 1939-1941.
25. Bray, R. A., C. Tarsitani, H. M. Gebel, and J. H. Lee. 2011. Clinical cytometry and progress in HLA antibody detection. Methods Cell Biol. 103: 285-310.
26. Lindemann, M., B. Nyadu, F. M. Heinemann, A. Kribben, A. Paul, P. A. Horn, and O. Witzke. 2010. High negative predicative value of an amplified flow cytometry crossmatch in living donor kidney transplantation. Hum. Immunol. 71: 771-776.
27. Spellman, S., R. Bray, S. Rosen-Bronsen, M. Haagenson, J. Klein, S. Flesh, C. Vierra-Green, and C. Anasetti. 2010. The detection of donor-directed HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 115: 2704-2708.
28. Ciurea, S. O., M. deLima, P. Cano, M. Korbling, S. Giralt, E. J. Shpall, X. Wang, P. F. Thall, R. E. Champlin, and M. Fernandez-Vina. 2009. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 88: 1019-1024.
29. Taylor, J. D., D. Briley, Q. Nguyen, K. Long, M. A. Iannone, M. S. Li, F. Ye, A. Afshari, E. Lai, M. Wagner, et al. 2001. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 30: 661-666, 668-669.
30. Couzi, L., C. Araujo, G. Guidicelli, T. Bachelet, K. Moreau, D. Morel, G. Robert, H. Wallerand, J. F. Moreau, J. L. Taupin, and P. Merville. 2011. Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay. Transplantation 91: 527-535.
31. Cecka, J. M., A. Y. Kucheryavaya, N. L. Reinsmoen, and M. S. Leffell. 2011. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches. Am. J. Transplant. 11: 719-724.
32. Cesbron-Gautier, A., P. Simon, L. Achard, S. Cury, G. Follea, and J. D. Bignon. 2004. Luminex technology for HLA typing by PCR-SSO and identification of HLA antibody specificities. Ann. Biol. Clin. (Paris) 62: 93-98. (Pubitemid 38215435)